Caricamento...
Next generation oncology drug development: opportunities and challenges
The optimal development of novel molecularly targeted agents for the treatment of cancer requires a re-evaluation of the current drug development paradigm. selection of patients, optimal biologic dose versus maximum tolerated dose, definition of response and clinical benefit and trial designs that a...
Salvato in:
| Pubblicato in: | Nat Rev Clin Oncol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2009
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7079165/ https://ncbi.nlm.nih.gov/pubmed/19390552 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2009.38 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|